Turn this list into pipeline.
Pharma Companies in London: 1,500+ Active Firms (2026)
Pharma companies in London develop, manufacture, license or distribute medicines within a regulated UK life-sciences market.
Buying activity tends to sit with clinical development, regulatory affairs, quality assurance, manufacturing operations and commercial supply teams, rather than a single technology or procurement function. London operators serve a mixed customer base: UK healthcare buyers, wholesale and hospital supply chains, overseas distributors, clinical trial sponsors and out-licensing partners. Engagements are typically formal, evidence-led and slow-moving, with contracts shaped by batch release, quality systems, pharmacovigilance duties, marketing permissions or supply continuity. The cohort therefore spans specialist research groups, importers, licence holders, distributors and commercialisation teams, with scale usually expressed through regulated capability rather than headcount alone.
Read more
London contains around 1,590 actively trading pharma companies in this cohort. The employment footprint is smaller than the company count might suggest: reported headcount totals 920 people, pointing to many entities that are licence-holding, specialist research, distribution or commercial vehicles rather than large manufacturing employers. A revenue tail is visible, with 72 companies above £5M turnover, while 417 were incorporated since 2022. That mix gives the capital a broad early-commercial layer alongside a narrower group of scaled operators, consistent with a market organised around clinical development, regulated import and distribution, licensing, and commercial access.
UK human medicines sit under MHRA oversight, with activity-specific permissions rather than a single blanket route to market. GOV.UK guidance requires organisations that make, assemble or import human medicines to hold a manufacturer’s licence, demonstrate good manufacturing practice and pass site inspections. Wholesale supply to anyone other than the patient requires a wholesale distribution licence and good distribution practice compliance. Medicines also need marketing authorisation, and public healthcare access is shaped by cost-effectiveness review after approval. The ABPI remains the main trade body for research-based pharmaceutical operators, so policy debates often centre on clinical trial approval, evidence requirements, pricing access and pharmacovigilance obligations.
London’s pharma base appears likely to remain split between specialist regulated functions and a smaller group of operators with enough commercial scale to absorb compliance, evidence and market-access costs. Early-commercial businesses tend to benefit from proximity to investors, universities, hospitals and advisers, but that same concentration can mask limited manufacturing depth. Distributor and licence-holder models may face continued margin pressure as quality systems, pharmacovigilance and supply assurance requirements keep fixed costs high. Consolidation appears more plausible where adjacent operators can share licences, regulatory teams or channel access, while research-led groups may stay project-based until clinical or licensing milestones support a larger organisation.
1,590
Active firms
2026
72
Above £5M
reported turnover
417
Since 2022
new incorporations
Key facts
About 4% of the trading cohort reports turnover above £5M (72 of 1,590 firms) — the rest sits below that revenue band.
26% of the cohort was incorporated since 2022 (417 firms), so a sizeable share is in its first few filing cycles.
UK human medicines sit under the MHRA, which sets standards, evaluates new treatments, approves clinical trials, licenses medicines and oversees pharmacovigilance.
Manufacturing, assembling or importing human medicines requires an MHRA manufacturer’s licence, good manufacturing practice compliance and regular site inspections.
Wholesale supply to anyone other than the patient requires a wholesale distribution licence and good distribution practice compliance.
UK businesses performed £9.0 billion of pharmaceutical R&D in 2022, equivalent to 0.36% of UK GDP and 18% of all UK business R&D.
UK pharmaceutical exports were valued at £25.6 billion in 2023, with the UK ranked tenth among comparator countries for this metric.
Top London pharma companies
Ria Generics Limited
Trajectory
5y · 2020–NowFinancial sub-scores
Computed from 5 filingsManufactures and wholesales generic pharmaceutical products. Acts as a marketing authorisation holder, importer and batch‑release site, and supplies licensed and unlicensed medicinal products to…
Serves pharmaceutical distributors and approved wholesale dealers in the UK and Europe, plus non-EU/UK brands requiring licensed or unlicensed generic medicines under their own label.
Financial Health
StrongStrong · Growing · 0% CAGR over 5y
Location
TARGET HEALTHCARE INTERNATIONAL LIMITED
Trajectory
5y · 2021–NowFinancial sub-scores
Computed from 5 filingsSupplies and manufactures generic, branded and unlicensed medicines to pharmacies, hospitals, dispensing doctors and wholesalers. Provides custom “specials” medicines, parallel imports, medical…
Serves pharmacies, hospitals, dispensing doctors, pharmaceutical wholesalers and buying groups in the UK and internationally, including healthcare providers and distributors needing licensed,…
Financial Health
StableStable · 1% CAGR over 4y
Location
PF Pharma Ltd
Trajectory
5y · 2019–NowFinancial sub-scores
Computed from 5 filingsProvides contract drug discovery, development and manufacturing services for pharmaceutical and biotechnology companies, including synthetic chemistry, API development and production, formulation of…
Sells to pharmaceutical innovators, biotech companies and academic research organisations, including teams managing pre-clinical, clinical and commercial drug programmes across small molecules,…
Financial Health
StrongStrong · Hiring · 35% CAGR over 5y
Location
A - Z HEALTHCARE ( UK ) LIMITED
Trajectory
5y · 2021–NowFinancial sub-scores
Computed from 5 filingsResearches, develops, manufactures and commercialises prescription medicines and vaccines. Focuses on therapeutic areas including oncology, cardiovascular, renal and metabolic diseases, respiratory…
Serves UK healthcare stakeholders including NHS organisations, healthcare professionals, patient groups, government and policy makers, alongside patients in specialist therapy areas such as oncology,…
Financial Health
HealthyHealthy · Hiring · 12% CAGR over 4y
Location
Researches, develops, manufactures and markets prescription medicines and therapies for a range of diseases. Activities include pharmaceutical research and clinical development, drug production, and…
Sells to a mix of UK healthcare professionals, patients and caregivers, and works with patient groups and healthcare organisations through partnerships, funding and sponsorships.
Location
Trajectory
5y · 2022–NowFinancial sub-scores
Computed from 5 filingsCommercialises and distributes pharmaceutical medicines for rare diseases and specialty care. Activities include marketing and sales, regulatory affairs, pharmacovigilance, quality assurance and…
Serves patients with rare diseases and specialty-care conditions, particularly rare metabolic, haematology, oncology and neurological disorders, working with healthcare systems and partners in more…
Financial Health
HealthyHealthy · Hiring · 3% CAGR over 4y
Location
Trajectory
3y · 2023–NowFinancial sub-scores
Computed from 3 filingsDevelops, in-licenses, manufactures and markets pharmaceutical products, focusing on generic and specialty medicines. Operates research and development and manufacturing for products including…
Serves healthcare markets with generic and specialty pharmaceutical products, selling primarily to healthcare providers, pharmacies and pharmaceutical distribution channels, while also partnering…
Financial Health
StableStable · 0% CAGR over 2y
Location
Develops, manufactures and commercialises pharmaceutical treatments, particularly long‑acting injectable medicines. Focuses on therapies in areas such as prostate cancer, central precocious puberty…
Serves patients and healthcare providers in urology, oncology and endocrinology, including prostate cancer, central precocious puberty and testosterone therapy markets; also addresses pharmaceutical…
Location
Trajectory
2y · 2022–NowFinancial sub-scores
Computed from 2 filingsProvides pharmaceutical distribution and regulatory compliance services for drug product owners, including supply chain planning, warehousing, quality release, order management and transport, as well…
Targets B2B pharmaceutical product owners, marketing authorisation holders, and life sciences companies managing medicines portfolios, especially firms commercialising or transferring products across…
Financial Health
StableStable · 9% CAGR over 1y
Location
GENETECH PHARMACEUTICALS LIMITED
Trajectory
4y · 2021–NowFinancial sub-scores
Computed from 4 filingsSupplies and distributes pharmaceutical and healthcare products. Provides NHS and pharmacy supply, international pharmaceutical exports, temperature‑controlled storage and logistics, manufacturer…
Serves NHS organisations, pharmacies, overseas healthcare professionals, pharmaceutical manufacturers and clinical trial sponsors needing pharmaceutical and healthcare product supply, distribution or…
Financial Health
StrongStrong · Hiring · 12% CAGR over 4y
Location
Develops and commercialises specialist pharmaceutical medicines, including antidotes, emergency treatments and therapies for rare diseases. Engages in acquisition, development, manufacturing and…
Serves healthcare providers, healthcare systems, governments, first responders, emergency preparedness agencies, and non-profit organisations worldwide, supplying specialist medicines for rare…
Location
SIMPLYPHARMACO LTD
Trajectory
5y · 2021–NowFinancial sub-scores
Computed from 5 filingsProvides pharmaceutical distribution and regulatory compliance services for drug product owners. Activities include supply chain planning, warehousing, quality release, order management, transport to…
Serves pharmaceutical product owners and life sciences companies that need outsourced distribution and regulatory compliance support for medicines, particularly firms commercialising products across…
Financial Health
HealthyHealthy · Hiring · 51% CAGR over 4y
Location
Ferring
Develops and commercialises biopharmaceutical medicines focused on reproductive medicine and maternal health, gastroenterology, urology and microbiome-related conditions. Conducts drug discovery,…
Serves patients, families and healthcare professionals globally in reproductive medicine, maternal health, gastroenterology, urology and uro-oncology.
Location
MEDEX PHARMA LIMITED
Trajectory
5y · 2021–NowFinancial sub-scores
Computed from 5 filingsImports, exports and wholesales branded and generic medicines, vaccines, over‑the‑counter medicines, and health and beauty products. Procures pharmaceutical stock from manufacturers and distributors,…
Serves pharmacies, pharmaceutical distributors, importers/exporters and healthcare businesses needing wholesale supply of medicines, vaccines, OTC and health products, including cold-chain lines, in…
Financial Health
HealthyHealthy · Hiring · 9% CAGR over 4y
Location
CELIX PHARMA LTD
Trajectory
5y · 2021–NowFinancial sub-scores
Computed from 5 filingsDevelops and commercialises generic and branded generic medicines and hospital specialty pharmaceuticals. Works with R&D and manufacturing partners to take products from development and regulatory…
Serves UK and European healthcare markets, selling to retail pharmacy and hospital channels, primary and secondary care providers, payers, and pharmaceutical partners.
Financial Health
HealthyHealthy
Location
Cadila Pharmaceuticals (UK) Limited
Trajectory
3y · 2023–NowFinancial sub-scores
Computed from 3 filingsDevelops and manufactures pharmaceutical products and active pharmaceutical ingredients (APIs). Conducts drug discovery and research, and provides formulation development, contract manufacturing and…
Serves pharmaceutical companies, healthcare systems, clinicians and patients, with B2B partners needing APIs, formulations, CDMO/CMO or contract research, and therapy markets including…
Financial Health
DistressedDistressed · -44% CAGR over 2y
Location
SILICON PHARMA LIMITED
Trajectory
5y · 2021–NowFinancial sub-scores
Computed from 5 filingsDistributes and wholesales prescription and over‑the‑counter medicines, medical devices, and pharmaceutical products. Provides sourcing and international supply, clinical trial medication…
Serves B2B healthcare and pharmaceutical customers, including community pharmacies, hospitals, healthcare partners, clinical trial teams, and global pharmaceutical supply partners in the UK and…
Financial Health
StrongStrong · Growing, Hiring · 19% CAGR over 4y
Location
Trajectory
5y · 2021–NowFinancial sub-scores
Computed from 5 filingsDevelops and commercialises biopharmaceutical medicines for rare diseases, with research and development focused on areas such as haematology and genetic disorders. Conducts clinical development,…
Serves healthcare professionals, hospitals and healthcare systems treating people with rare and debilitating diseases, including haematology, haemophilia and other rare-disease patient communities…
Financial Health
StrongStrong · Growing, Hiring · 16% CAGR over 4y
Location
FLAMINGO PHARMA (UK) LTD
Trajectory
3y · 2023–NowFinancial sub-scores
Computed from 3 filingsWholesales prescription and over‑the‑counter pharmaceutical products. Acquires, develops and markets generic medicines, supplying tablets, capsules and other treatments through licensing,…
Serves B2B customers in the UK pharmaceuticals market, including healthcare providers and partners seeking generic medicines, own-label supply arrangements and product availability information.
Financial Health
HealthyHealthy · -88% CAGR over 2y
Location
Develops, manufactures and supplies generic and branded generic pharmaceutical medicines across multiple therapeutic areas. Provides product information and resources for healthcare professionals and…
Serves the NHS, healthcare professionals and healthcare partners in the UK, with products intended for patients across multiple therapeutic areas.
Location
Trajectory
4y · 2022–NowFinancial sub-scores
Computed from 4 filingsDevelops, manufactures, markets and distributes generic pharmaceutical medicines. Supplies a range of prescription drugs including analgesics, cardiovascular and antibiotic treatments such as…
Serves NHS contractors, pharmaceutical suppliers and wholesale/distribution buyers in the UK market for generic medicines.
Financial Health
WeakWeak
Location
MEDPHARMA LIMITED
Trajectory
5y · 2021–NowFinancial sub-scores
Computed from 5 filingsProvides pharmaceutical development and manufacturing services for drug products, particularly topical and transdermal therapies. Offers formulation development, analytical and bioanalytical testing,…
Serves pharmaceutical and biotech companies developing topical, transdermal and other specialty drug products, from early-stage development through clinical supply and commercial manufacturing.
Financial Health
WeakWeak · Hiring · 17% CAGR over 4y
Location
Develops and commercialises biopharmaceutical medicines. Conducts research, clinical development, and partnerships to produce treatments in areas including oncology, rare diseases, and neuroscience,…
Serves patients through healthcare systems, clinicians and specialist providers in oncology, rare disease and neuroscience. Targets partners in biopharma and research through collaborations and…
Location
PHARMAPOINT UK LTD
Trajectory
3y · 2023–NowFinancial sub-scores
Computed from 3 filingsWholesale distributor of pharmaceutical products, supplying prescription medicines, over‑the‑counter drugs and vitamin supplements to wholesalers and pharmacy retailers. Holds marketing…
Sells B2B to UK pharmaceutical wholesalers, pharmacy retail stores and chain pharmacies, with supply into general retail outlets such as supermarkets and newsagents.
Financial Health
StableStable · 0% CAGR over 2y
Location
Cultivates, processes and manufactures pharmaceutical‑grade cannabis products for medical use. Distributes medical cannabis to clinics and pharmacies, operates medical cannabis clinics and an online…
Serves medical cannabis patients, healthcare professionals, specialist clinics and pharmacies, and cannabis businesses or distributors seeking regulated supply across Europe, Australasia and other…
Location
BRUNSWICK TRADING LIMITED
Trajectory
3y · 2022–NowFinancial sub-scores
Computed from 3 filingsProvides wholesale procurement and distribution of pharmaceutical and healthcare products, including UK generic and branded medicines, medical devices and dressings. Also conducts parallel import and…
Serves licensed pharmaceutical wholesalers, distributors and healthcare product businesses sourcing generics, branded medicines, medical devices and dressings across Europe, the Middle East and…
Financial Health
DistressedDistressed · -11% CAGR over 2y
Location
L.D. COLLINS & CO. LIMITED
Trajectory
5y · 2021–NowFinancial sub-scores
Computed from 5 filingsDevelops and supplies progesterone-based fertility medication, including Cyclogest, used in assisted reproductive technology and pregnancy support. Provides medical information and educational…
Serves people undergoing fertility treatment, fertility healthcare professionals, and distribution partners, with emphasis on women and couples affected by infertility, IVF and assisted reproduction.
Financial Health
HealthyHealthy · -2% CAGR over 4y
Location
Pierre Fabre
Develops and manufactures pharmaceutical medicines and dermocosmetic products. Conducts research and development in prescription drugs, treatments for cancer, chronic and everyday ailments, and…
Targets a mix of B2B and B2C audiences: healthcare professionals, patients and consumers in pharmaceutical and dermocosmetic markets, including skin, hair and oral care users and people affected by…
Location
Accord Healthcare
Develops, manufactures and distributes generic, biosimilar and value‑added pharmaceutical medicines for hospital and retail pharmacies. Product portfolio covers areas including oncology, cardiology,…
Serves hospital and retail pharmacies, healthcare providers and patient organisations worldwide, including buyers in oncology, critical care, autoimmune and central nervous system therapy areas.
Location
Trajectory
2y · 2022–NowProvides pharmaceutical distribution and regulatory compliance services for drug product owners. Activities include supply chain planning, warehousing, order management, transportation to customers,…
Serves B2B pharmaceutical product owners, marketing authorisation holders and biotech/pharma companies needing outsourced distribution and regulatory compliance support for medicines across Europe…
Financial Health
Insufficient historyInsufficient history
Location
Researches, develops and commercialises medicines for serious diseases. Operates pharmaceutical R&D programmes and clinical trials focused on conditions including cystic fibrosis, sickle cell…
Serves patients with serious diseases, including cystic fibrosis, sickle cell disease, beta thalassemia, kidney diseases, pain and type 1 diabetes, alongside healthcare professionals and research…
Location
E-Pharm Ltd
Trajectory
5y · 2021–NowFinancial sub-scores
Computed from 5 filingsSupplies and distributes pharmaceutical products, specialising in sourcing comparator drugs, newly launched medicines, and hard‑to‑obtain or unlicensed medicines for clinical research and healthcare…
Serves pharmaceutical and clinical trial organisations, healthcare providers and pharmacies needing comparator drugs, unlicensed medicines, and hard-to-obtain or newly launched medicines.
Financial Health
HealthyHealthy · Growing, Hiring · 5% CAGR over 4y
Location
HNS PHARMA LIMITED
Trajectory
5y · 2021–NowFinancial sub-scores
Computed from 5 filingsSupplies and distributes pharmaceutical products, including licensed, unlicensed and controlled medicines. Sources drugs globally for healthcare providers, supports clinical trials with comparator…
Serves government and private pharmaceutical buyers, clinical trial teams, aid and development organisations, and UK NHS and healthcare providers needing licensed, unlicensed, controlled or…
Financial Health
WeakWeak · Hiring · 3% CAGR over 4y
Location
MACURE PHARMA UK LIMITED
Trajectory
3y · 2023–NowFinancial sub-scores
Computed from 3 filingsDevelops, licenses and commercialises niche pharmaceutical products across multiple therapeutic areas. Partners with pharmaceutical manufacturers to market and distribute medicines and mature drug…
Serves healthcare professionals, pharmaceutical partners and patients across Europe and selected export markets, addressing niche pharmaceutical needs across multiple therapeutic areas.
Financial Health
StableStable · Hiring · 15% CAGR over 2y
Location
BLOSSOM GENETICS CORPORATION LTD
Trajectory
5y · 2020–NowFinancial sub-scores
Computed from 5 filingsProvides EU‑GMP contract manufacturing for medical cannabis and narcotics‑based pharmaceuticals, including API and finished product processing, primary packaging, labelling, storage, distribution,…
Serves B2B pharmaceutical and medical cannabis companies, cannabis brands and global partners entering European markets that require EU-GMP manufacturing, packaging, distribution and product release…
Financial Health
HealthyHealthy · -66% CAGR over 5y
Location
Trajectory
5y · 2021–NowFinancial sub-scores
Computed from 5 filingsResearches, develops and licenses generic pharmaceutical products for human and veterinary use, focusing on complex and niche molecules. Works with contract manufacturers to produce medicines and…
Serves B2B pharmaceutical and healthcare customers, including payors, healthcare providers, wholesalers, prescribers and pharmacies, plus companies seeking licensing, acquisitions, co-development or…
Financial Health
StableStable · Hiring · 19% CAGR over 4y
Location
QMED PHARMACEUTICALS LTD
Trajectory
5y · 2021–NowFinancial sub-scores
Computed from 5 filingsProvides pharmaceutical support services including sourcing medicines, overlabelling and repackaging drugs, supplying unlicensed medicines, distributing pharmaceutical products, and supporting…
Serves NHS trusts, private healthcare organisations, and pharmaceutical or healthcare organisations across the UK, including procurement teams needing overlabelled medicines, unlicensed medicines,…
Financial Health
StrongStrong · Growing, Hiring · 20% CAGR over 4y
Location
AB BIOTECHNOLOGY LIMITED
Trajectory
4y · 2023–NowFinancial sub-scores
Computed from 4 filingsDevelops and manufactures biopharmaceutical products for research and clinical use. Provides services including peptide synthesis, protein purification, assay development, polyclonal antibody…
Serves biotechnology and pharmaceutical organisations developing biological medicinal or investigational medicinal products, including R&D, quality and manufacturing teams needing GMP-grade…
Financial Health
WeakWeak · -79% CAGR over 3y
Location
ADALLEN PHARMA LIMITED
Trajectory
3y · 2023–NowFinancial sub-scores
Computed from 3 filingsSources and supplies comparator drugs, biosimilars and controlled medicines for clinical trials. Provides pharmaceutical supply chain services including procurement, temperature‑controlled logistics,…
Sells B2B to pharmaceutical companies, clinical researchers and trial sponsors needing comparator drugs, biosimilars, controlled drugs, ancillaries and medical devices for international clinical…
Financial Health
HealthyHealthy · 4% CAGR over 2y
Location
WEST LODGE CAPITAL NUMBER THREE LIMITED
Trajectory
1y · 2025–NowSupplies pharmaceuticals and medical products globally, including clinical trial materials, unlicensed and specialty medicines, and sexual health supplies. Provides expanded access programmes, global…
Serves pharmaceutical and healthcare manufacturers, clinical trial sponsors, healthcare professionals, aid and development organisations, and sexual health providers needing access to medicines and…
Financial Health
Insufficient historyInsufficient history
Location
AOP ORPHAN LTD
Trajectory
5y · 2021–NowFinancial sub-scores
Computed from 5 filingsDevelops and commercialises pharmaceutical therapies for rare diseases and critical care. Conducts preclinical research, clinical development and regulatory activities, and markets treatments in…
Serves healthcare providers, hospitals and patients in rare diseases and critical care, particularly cardiology, pulmonology, hemato-oncology and advanced therapies, with a European and global reach.
Financial Health
StableStable · -61% CAGR over 4y
Location
Trajectory
3y · 2024–NowFinancial sub-scores
Computed from 3 filingsDevelops and commercialises pharmaceutical treatments for rare diseases, with a focus on Duchenne muscular dystrophy. Conducts research and development and supports distribution of specialty…
Serves UK patients with rare diseases, particularly Duchenne muscular dystrophy, alongside specialist healthcare professionals and physicians in related specialty therapy areas.
Financial Health
HealthyHealthy · -70% CAGR over 2y
Location
CELLTRION HEALTHCARE UNITED KINGDOM LIMITED
Trajectory
5y · 2021–NowFinancial sub-scores
Computed from 5 filingsMarkets, sells and distributes biopharmaceutical products, including biosimilar medicines, to healthcare providers in the UK. Supports the commercialisation of biosimilar therapies developed by its…
Financial Health
StrongStrong · Hiring · 21% CAGR over 4y
Location
Trajectory
5y · 2020–NowFinancial sub-scores
Computed from 5 filingsResearches, develops, manufactures and markets pharmaceutical medicines, particularly treatments for diabetes, obesity and other chronic diseases. Conducts drug discovery and clinical development and…
Serves patients, healthcare professionals and healthcare systems seeking medicines for diabetes, obesity and other serious chronic diseases in authorised local markets.
Financial Health
DistressedDistressed
Location
Orchard Pharm Limited
Trajectory
5y · 2021–NowFinancial sub-scores
Computed from 5 filingsDevelops, manufactures and markets pharmaceutical products, with integrated capabilities in drug research, formulation development and production. Operates across multiple therapeutic areas and…
Financial Health
StrongStrong · Growing, Hiring · 9% CAGR over 4y
Location
BROWN & BURK UK LIMITED
Trajectory
5y · 2020–NowFinancial sub-scores
Computed from 5 filingsManufactures, markets and distributes generic pharmaceutical medicines. Supplies EU GMP‑compliant products including antibiotics and other prescription drugs, and manages pharmaceutical supply chains…
Serves B2B healthcare and pharmaceutical buyers, including distributors and supply-chain partners sourcing generic medicinal products across the UK and Europe.
Financial Health
HealthyHealthy · -51% CAGR over 5y
Location
Trajectory
5y · 2021–NowFinancial sub-scores
Computed from 5 filingsMarkets pharmaceutical products and provides pharmacovigilance activities including adverse event reporting and safety monitoring for medicines, alongside information on its product portfolio and…
Financial Health
StableStable · -68% CAGR over 4y
Location
WORLD MEDICINE LIMITED
Trajectory
5y · 2021–NowFinancial sub-scores
Computed from 5 filingsManufactures pharmaceutical products, focusing on accessible medicines produced to international quality standards. Activities include development and production of drug formulations using controlled…
Financial Health
StableStable · -68% CAGR over 4y
Location
Trajectory
3y · 2023–NowFinancial sub-scores
Computed from 3 filingsMarkets and supplies generic pharmaceutical medicines to wholesale distributors, pharmacies, and healthcare providers. Licenses and markets medicines from third parties and develops generic drugs…
Serves UK pharmaceutical wholesalers, retail pharmacy channels and secondary care healthcare providers, with additional relationships with third-party product licensing partners.
Financial Health
WeakWeak · Hiring · 6% CAGR over 2y
Location
SUERTE PHARMA LIMITED
Trajectory
5y · 2020–NowFinancial sub-scores
Computed from 5 filingsHolds parallel import licences and provides pharmaceutical re‑labelling and re‑packaging services. Prints labels, braille and patient leaflets, manages FMD decommissioning and recommissioning, and…
Serves pharmaceutical companies and medicine supply chain businesses needing licensed parallel import, re-labelling and re-packaging services, within a regulated UK medicines market.
Financial Health
StableStable · Hiring · 134% CAGR over 4y
Location
Unlock all 1,590 leads
Showing 50 of 1,590 — +1,540 more with verified decision-maker contacts, live data, and CRM sync.
How London pharma companies work and how to sell to them
What they do
Revenue is usually tied to regulated medicine supply rather than pure research activity. London pharma companies earn from authorised product sales, import and wholesale margins, development services, out-licensing income, milestone payments and royalties. Engagement size depends on the route to market: small specialist batches and trial supply can sit alongside multi-year distribution, commercialisation or manufacturing arrangements. Pricing tends to be per pack, per batch, per shipment, transfer price, project fee or royalty share, with extra cost attached to quality documentation, storage conditions, release checks and pharmacovigilance cover.
Who they sell to
Customers are typically healthcare providers, wholesalers, hospital supply teams, clinical trial sponsors, overseas distributors, research partners and public-sector procurement teams. Decision-making often involves regulatory affairs, quality assurance, medical, procurement, finance and supply-chain roles, rather than a single buyer. Sales cycles are usually measured in months rather than weeks because qualification, audit trails, product evidence and contractual liability matter. Routes to market tend to mix direct account management, tendering, distributor agreements, RFPs and partner-led commercialisation, with price only one part of the approval process.
What they buy
Most London pharma firms tend to spend on systems and services that protect licence status, release timelines and supply continuity. Common buying areas include quality management software, document control, regulatory information management, pharmacovigilance workflow, ERP, validated cloud hosting, cyber security, laboratory systems, cold-chain logistics, insurance and audit support. They also buy specialist legal, accounting, tax, regulatory consulting, medical writing, market-access, recruitment and training services. Hiring demand often centres on quality assurance, regulatory affairs, clinical operations, qualified-person cover, supply-chain management and commercial access roles.
Why and how to sell to them
Buying windows tend to open around licence applications, inspection preparation, new distribution agreements, clinical milestone movement, marketing authorisation work, leadership changes, funding events and hiring into quality or regulatory teams. Pain points are practical: audit readiness, document retrieval, batch traceability, case reporting, supplier qualification, stock visibility and margin pressure from fixed compliance costs. Outbound messaging usually lands better when it maps to a regulated workflow and names the operational risk reduced, such as fewer release delays, clearer evidence packs, cleaner supplier oversight or faster response during an MHRA query.
How this list is built
Data sources
This list is built from UK Companies House filings, XBRL accounts data, and semantic analysis of each company's public website. Revenue and headcount figures come from the most recent filed accounts; where the company has not filed, values are estimated using a model trained on filed history and peer benchmarks and are labelled as estimates.
Classification
Rather than relying solely on SIC codes, Firmbase classifies each company semantically: the company's website is crawled, an AI model reads what the company actually sells, and the company is placed into the relevant industry and subsectors. SIC codes are used as one signal but not the only one. This means a company that registered under a generic SIC code but pivoted into (for example) fintech is correctly identified as fintech, not as its original SIC category.
Freshness
The underlying company data is refreshed from Companies House continuously; filings appear in the list within days of submission. The curated list ordering is regenerated when the underlying data moves meaningfully (company count changes by more than 5%, a new company enters the top-ranked segment, or the filed-revenue numbers for the top firms change). You can see the last-updated timestamp near the top of the page.
Also in London
Related directories
Frequently asked questions
How many pharma companies are there in the London?↓
What counts as a pharma company in this list?↓
Which are the largest pharma companies in the London?↓
What do pharma companies in the London actually do?↓
How does London pharma compare internationally?↓
How is this list built and how fresh is the data?↓
How big are the typical pharma companies in the London?↓
Are these mostly new or established pharma companies?↓
What SIC codes does this use?↓
What buying signals should I look for?↓
Push these 1,590 companies into your pipeline.
Find the right decision-makers, see verified company data, and export your list in seconds.